Ampa Names Former Cigna Group Behavioral Health CMO Dr. Doug Nemecek as Advisor to Support Payer Strategy and Outcomes-Based TMS Care
PALO ALTO, Calif., June 23, 2026 /PRNewswire/ -- Ampa, a Palo Alto-based neurotechnology company making transcranial magnetic stimulation (TMS) more measurable, scalable, and practical for mental health treatment, today announced that Dr. Doug Nemecek, former Chief Medical Officer of...
PALO ALTO, Calif., June 23, 2026 /PRNewswire/ -- Ampa, a Palo Alto-based neurotechnology company making transcranial magnetic stimulation (TMS) more measurable, scalable, and practical for mental health treatment, today announced that Dr. Doug Nemecek, former Chief Medical Officer of...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.